INSIGHT FOR EYESIGHT – Novel mRNA medicines for eye disease

Project description

Pioneering mRNA therapy could promote healing and reduce loss of vision

Fields of science

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery
• medical and health sciences › clinical medicine › ophthalmology › glaucoma
• medical and health sciences › clinical medicine › surgery
• medical and health sciences › clinical medicine › ophthalmology › retinopathy
• natural sciences › biological sciences › genetics › RNA

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.2.3.2.2. - Enhancing the innovation capacity of SMEs

Topic(s)

• INNOSUP-02-2019-2020 - European SME innovation Associate - pilot

Call for proposal

H2020-INNOSUP-2018-2020

See other projects for this call

Sub call

H2020-INNOSUP-2019-02

Funding Scheme

CSA - Coordination and support action

Coordinator

MERCURNA BV

Net EU contribution

€ 75 937,50

Address

Geurdeland 17g
6673 DR Andelst
Netherlands

Region

Oost-Nederland › Gelderland › Arnhem/Nijmegen

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Non-EU contribution

€ 0,00